News

MedPage Today2d
Pulsed Field Ablation's Safety Challenged by Evidence of Collateral Damage
PFA is a newer Afib ablation modality touted as reducing the risk of damaging nearby collateral structures, compared with ...
Sickle Cell Disease Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies
In April 2025, Kamau Therapeutics announced a study is a first-in-human, single-arm, open-label Phase I/II study of nula-cel ...